Kangstem Biotech Co. Ltd (217730) — Cash Flow Reinvestment Rate
Latest as of June 2019:
6.10x
Kangstem Biotech Co. Ltd (217730) has a Cash Flow Reinvestment Rate of 6.10x as of June 2019, reinvesting ₩6.86 Billion (capex ₩1.18 Billion plus investments ₩5.68 Billion) from operating cash flow of ₩1.12 Billion. Check 217730 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
6.10x
(Capex + Investments) / Operating CF
Total Reinvested
₩6.86 Billion
Capex + Investments
Operating Cash Flow
₩1.12 Billion
KRW
Capital Expenditures
₩1.18 Billion
KRW
Annual Cash Flow Reinvestment Rate for Kangstem Biotech Co. Ltd (None–None)
Year-by-year capital reinvestment analysis for Kangstem Biotech Co. Ltd. For live market cap and broader valuation context, see 217730 company net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow